Largest ever real-world analysis of Cardiac Implantable Electronic Device (CIED) infection treatment presented at the American College of Cardiology’s 71st Annual Scientific Session [1] demonstrates that approximately 4 in 5 patients are not treated according to HRS/EHRA Class I guidelines [2,3] for CIED infection In the absence of guideline-driven care, the risk of death after […]
Tag: ACC.22
ACC.22: Medtronic renal denervation system demonstrates significant blood pressure reduction through three years
Medtronic adds to its robust clinical program with long-term data demonstrating the continued blood pressure lowering effect of the Symplicity renal denervation procedure Medtronic also completes enrollment in the SPYRAL HTN-ON MED trial DUBLIN and WASHINGTON, April 4, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced long-term data from the first 80 patients […]
egnite, Inc. Announces Data from the Largest Contemporary Analysis of Valvular Heart Disease Prevalence in the United States
– Data to Be Presented at 2022 ACC Annual Meeting Demonstrate Valve Disease is More Common in Women in the U.S. – – Other Key Findings Suggest Tricuspid and Mitral Regurgitation Have Highest Prevalence Rates; Severe Mitral Regurgitation Diagnosed More Frequently in Centers Offering Percutaneous Mitral Therapies – ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, Inc., an advanced technology […]